Table 5.
Glioblastoma | NICHE 1 | NICHE 2 | NICHE 3 | NICHE 4 | NICHE 5 | NICHE 6 | NICHE 7 | NICHE 8 | NICHE 9 | NICHE 10 | NICHE 11 | NICHE 12 | NICHE 13 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total number of cells (DAPI) | 445 | 480 | 390 | 295 | 426 | 394 | 411 | 288 | 402 | 388 | 427 | 456 | 367 |
Number of CD133/SOX2 GSCs | 180 | 200 | 156 | 140 | 122 | 163 | 153 | 134 | 200 | 176 | 169 | 175 | 145 |
Number of CD105 MSCs | 102 | 100 | 97 | 86 | 77 | 86 | 106 | 74 | 102 | 88 | 93 | 100 | 73 |
Percentage GSCs | 40.45 | 41.67 | 40.00 | 47.46 | 28.64 | 41.37 | 37.23 | 46.53 | 49.75 | 45.36 | 39.58 | 38.38 | 39.51 |
Percentage MSCs | 22.92 | 20.83 | 24.87 | 29.15 | 18.08 | 21.83 | 25.79 | 25.69 | 25.37 | 22.68 | 21.78 | 21.93 | 19.89 |
Abbreviations: GSC, glioblastoma stem cell; DAPI, 4,’6-diamidino-2-phenylindole; SOX2, sex determining region Y-box 2; MSC, mesenchymal stem cell.